Literature DB >> 34878011

Prevalence and factors associated to cervical changes in units from the Single Health System.

Indianara Carlotto Treco1, Valquíria Kulig Vieira1, Janaína Carla da Silva1, Fernando Rodrigo Treco2, Lirane Elize Defante Ferreto1,2, Léia Carolina Lucio1,2.   

Abstract

OBJECTIVE: To estimate the prevalence and risk factors associated with cytopathological changes in the uterine cervix of women treated by the Unified Health System.
METHOD: This is a cross-sectional study carried out with 350 women, between 14 and 79 years old who underwent pap smear tests in heath units in Francisco Beltrão, Paraná. Cervical cytopathological analyses and a questionnaire were applied to obtain socioeconomic information, as well as data on sexual behavior, gynecological aspects, and life habits. Chi-square test and logistic regression with p <0.05 were applied for statistical analysis.
RESULTS: The prevalence of cervical changes was 3.4% and the main categories found were low-grade cervical intraepithelial lesion, high-grade cervical intraepithelial lesion, and atypical cells of undetermined significance. From these, the first were present in 16.6% of women under 25 years old. The multivariate analysis pointed at associations between previous results of the cytopathology test (OR = 25.693), smoking (OR = 7.576), and oral contraceptives (OR = 5.265) and the outcome.
CONCLUSION: Women with a history of previous cervical cytopathological abnormality, use of oral contraceptives, and smokers were more likely to have an abnormal result in the pap smear test.

Entities:  

Mesh:

Year:  2021        PMID: 34878011     DOI: 10.1590/1983-1447.2021.20200233

Source DB:  PubMed          Journal:  Rev Gaucha Enferm        ISSN: 0102-6933


  1 in total

1.  GSTT1 and GSTM1 polymorphisms with human papillomavirus infection in women from southern Brazil: a case-control study.

Authors:  Ana Paula Reolon Bortolli; Valquíria Kulig Vieira; Indianara Carlotto Treco; Claudicéia Risso Pascotto; Guilherme Welter Wendt; Léia Carolina Lucio
Journal:  Mol Biol Rep       Date:  2022-05-04       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.